Access, Influence, and Tariff Talks

Andrew, Tom and Carl discuss Monday’s decision to dismiss Special Counsel Jack Smith’s cases against Donald Trump, and President Biden’s proposal to add Medicare and Medicaid coverage for Ozempic and other weight loss drugs – a move opposed by Trump’s HHS Secretary nominee Robert F. Kenney Jr. They also talk about reports that longtime Trump insider and aide Boris Epshteyn is the subject of an internal probe by Trump’s attorneys for trying to sell access to the President Elect. Plus, a look at repercussions from Trump’s plan to place a 25% tariff on imports from Canada and Mexico. Next, Tom Bevan talks to RCP senior elections analyst Sean Trende about whether the 2024 results were “Trump-specific” or reveal a long-term trend within the GOP, and why California takes so long to count votes. And finally, Andrew Walworth talks to Republican strategist John Feehery about how Speaker Mike Johnson will lead given his slender majority in the House, and what the nomination of former GOP Rep. Lori Chavez-DeRemer for Labor Secretary will mean for public sector unions.